Japanese Nationwide PCI (J-PCI) Registry Annual Report 2019: patient demographics and in-hospital outcomes

Cardiovascular Intervention and Therapeutics - 2022
Hirohiko Ando1, Kyohei Yamaji2, Shun Kohsaka3, Hideki Ishii4, Hideki Wada5, Sumio Yamada6, Mitsuaki Sawano7, Taku Inohara3, Yohei Numasawa8, Yuji Ikari9, Tetsuya Amano1, NULL AUTHOR_ID
1Department of Cardiology, Aichi Medical University, 1-1 Yazakokarimata, Nagakute, Aichi, 480-1195, Japan
2Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan
3Department of Cardiology, Keio University School of Medicine, Tokyo, Japan
4Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Gunma, Japan
5Department of Cardiovascular Medicine, Juntendo University Shizuoka Hospital, Izunokuni, Japan
6Department of Health Sciences, Nagoya University, Graduate School of Medicine, Nagoya, Japan
7Department of Cardiology Assistant Researcher, Tokyo Dental College Ichikawa General Hospital, Tokyo, Japan
8Department of Cardiology, Japanese Red Cross Ashikaga Hospital, Ashikaga, Japan
9Department of Cardiology, Tokai University School of Medicine, Kanagawa, Japan

Tóm tắt

Từ khóa


Tài liệu tham khảo

Sawano M, Yamaji K, Kohsaka S, Inohara T, Numasawa Y, Ando H, et al. Contemporary use and trends in percutaneous coronary intervention in Japan: an outline of the J-PCI registry. Cardiovasc Interv Ther. 2020;35:218–26. https://doi.org/10.1007/s12928-020-00669-z.

Kimura K, Kimura T, Ishihara M, Nakagawa Y, Nakao K, Miyauchi K, et al. JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome. Circ J. 2019;83:1085–196. https://doi.org/10.1253/circj.CJ-19-0133.

Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40:87–165. https://doi.org/10.1093/eurheartj/ehy394.

Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O’Brien SM, Boden WE, et al. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med. 2020;382:1395–407. https://doi.org/10.1056/NEJMoa1915922.

Niimi N, Sawano M, Ikemura N, Nagai T, Nakano S, Shoji S, et al. Applicability and eligibility of the international study of comparative health effectiveness with medical and invasive approaches (ISCHEMIA) for patients who underwent revascularization with percutaneous coronary intervention. J Clin Med. 2020;2020:9. https://doi.org/10.3390/jcm9092889.

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–20. https://doi.org/10.1056/NEJMoa2002032.

Ikari Y, Yamada S, Ehara N, Kozuma K, Shinke T, Sugano T, et al. The Japanese Association of Cardiovascular Intervention and Therapeutics position statement on coronary invasive procedures during the COVID-19 pandemic in Japan. Cardiovasc Interv Ther. 2021;36:139–44. https://doi.org/10.1007/s12928-021-00767-6.

Ishii H, Amano T, Yamaji K, Kohsaka S, Yokoi H, Ikari Y. Implementation of Percutaneous Coronary Intervention During the COVID-19 Pandemic in Japan—nationwide survey report of the japanese association of cardiovascular intervention and therapeutics for cardiovascular disease. Circ J. 2020;84:2185–9. https://doi.org/10.1253/circj.CJ-20-0708.

Ishii H, Amano T, Kohsaka S, Morino Y, Yokoi H, Ikari Y. National survey of percutaneous coronary intervention during the COVID-19 pandemic in Japan: second report of the Japanese Association of Cardiovascular Intervention and Therapeutics. Cardiovasc Interv Ther. 2021. https://doi.org/10.1007/s12928-021-00776-5.

Thông tin
Thông tin xuất bản

Cardiovascular Intervention and Therapeutics

Thông tin tác giả